Cardiovascular Reserve in Patients with Systemic Autoimmune Diseases

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONC-12002365

Enrollment

Unknown

Registered

2012-07-22

Start date

2012-07-04

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic Autoimmune Diseases

Interventions

1:NA

Eligibility

Sex/Gender

Male

Age

No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Patients with SLE or PsA, Control subjects who are considered to have a low probability of coronary artery disease on clinical grounds and have a normal exercise stress echocardiogram.

Exclusion criteria

Exclusion criteria: Hypertension, significant atrial or ventricular arrhythmia, significant valvular diseases (>moderate severity), significant coronary artery disease, prior history of myocardial infarction, impaired LV systolic function (ejection fraction<50%, or any regional wall motion abnormality), pericardial disease and unable to exercise.

Design outcomes

Primary

Measure	Time frame
Changes in resting cardiac function and functional;Increased arterial stiffness in resting and impair;Association among early cardiovascular dysfunction;	—

Contacts

Public ContactQing SHANG

qingshang@cuhk.edu.hk+852 2632 3840

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026